← back to search

Gabrielle Rizzuto

Weill Cornell Medicine · US
Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, and CAR-T cell therapy research.
h-index
26
citations
3,781
works
80
NIH funding
primary concept
Biology
email

Recent publications

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
Cell 2023cited by 290position: middledoi
A spatially resolved timeline of the human maternal–fetal interface
Nature 2023cited by 166position: middledoi
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies
Nature Immunology 2023cited by 56position: middledoi
A single-amino acid substitution in the adaptor LAT accelerates TCR proofreading kinetics and alters T-cell selection, maintenance and function
Nature Immunology 2023cited by 34position: middledoi
Establishment of fetomaternal tolerance through glycan-mediated B cell suppression
Nature 2022cited by 72position: firstdoi
Listeria monocytogenes InlP interacts with afadin and facilitates basement membrane crossing
PLoS Pathogens 2018cited by 48position: middledoi
34: Comprehensive characterization of human decidual immune cells involvement in spiral artery remodelling
American Journal of Obstetrics and Gynecology 2018cited by 0position: middledoi
Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes
Malaria Journal 2017cited by 72position: middledoi
H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition
Journal of Clinical Investigation 2017cited by 60position: middledoi
InlP, a New Virulence Factor with Strong Placental Tropism
Infection and Immunity 2016cited by 66position: middledoi
Clonal Abundance of Tumor-Specific CD4 + T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion
Immunity 2016cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marc Bossé · Stanford University2 papers (2018–2023)Shirley Greenbaum · Palo Alto University2 papers (2018–2023)Leeat Keren · Weizmann Institute of Science2 papers (2018–2023)Cristina Faralla · AbCellera (Canada)2 papers (2016–2018)Matt van de Rijn · Stanford Medicine2 papers (2018–2023)Anna I. Bakardjiev · Vir Biotechnology (Switzerland)2 papers (2016–2018)Adrian Erlebacher · University of California, San Francisco2 papers (2017–2022)Moses R. Kamya · Universidad Católica de Santa Fe1 papers (2017–2017)H. Atakan Ekiz · Izmir Institute of Technology1 papers (2023–2023) · 1 papers (2023–2023)Sham Rampersaud · University of California, San Francisco1 papers (2023–2023)James Kapisi · Makerere University1 papers (2017–2017)Xia Yang · Sun Yat-sen University Cancer Center1 papers (2016–2016)Stephanie L. Gaw · University of California, San Francisco1 papers (2017–2017)Lei Gao · The University of Texas Southwestern Medical Center1 papers (2018–2018)Hong Zhong · Guhua Hospital1 papers (2016–2016)Travis J. Hollmann · Bristol-Myers Squibb (United States)1 papers (2023–2023)S. Ma · University of California, San Francisco1 papers (2022–2022)Salvatore Nocadello · Northwestern University1 papers (2018–2018) · 1 papers (2023–2023)